Subscribe for free to the America First Report newsletter.
Former President Donald Trump continues to dominate the crowded Republican primary field as he makes his third bid for the White House.
Polling analysts emphasized how “unprecedented” and “unique” this cycle is, considering a former president is heavily in the lead with two federal indictments under his belt, they told the Daily Caller News Foundation.
“This GOP primary is truly unprecedented, because Trump is not technically an incumbent, but Republican voters seem to be treating him as at least a quasi-incumbent,” Kyle Kondik, nonpartisan polling analyst and managing editor for Sabato’s Crystal Ball at the University of Virginia’s Center for Politics, told the DCNF.
Former President Donald Trump continues to dominate the early primary season in an unprecedented third bid for the White House, polling experts told the Daily Caller News Foundation.This Republican primary cycle is like none other as the frontrunner is a former president, has a massive […]
Excerpt Sourced From: conservativeplaybook.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.